Pfizer’s investigational therapy inclacumab failed to outperform a placebo in reducing vaso-occlusive crises in SCD patients ...

Columnist Oluwatosin Adesoye shares the qualities she looks for in a romantic partner as someone living with sickle cell ...

In her final column, Sylvia Amuta reflects on all she's learned from her experience as a caregiver to her young cousin with ...

People with sickle cell disease may have a higher risk of developing blood cancer, but a lower risk for certain types of ...

Women with SCD have nearly double the rate of acute pain late in pregnancy and right after than in the months following birth ...

I’ve shared reflections from three days after my last sickle cell pain crisis, and then again a month later. Now, four months on, I find myself in a completely different place physically, mentally, ...

The FDA has granted regenerative medicine advanced therapy designation to BEAM-101, a one-time, gene-edited cell therapy for severe SCD.

Children with SCD who have sleep issues, such as sustained low blood oxygen during sleep, require more healthcare resources, ...

The gene-editing therapy OTQ923 normalized brain blood flow in 3 sickle cell disease patients, suggesting it may lower stroke risk, a study says.

Acute chest syndrome associated with sickle cell is driven by the abnormal activation of the complement cascade, per a study.

The Centers for Medicare & Medicaid Services (CMS) has announced that 33 states, along with the District of Columbia and Puerto Rico, have agreed to participate in the Cell and Gene Therapy (CGT) ...